Cargando…

Clinical Features in Parkinson’s Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study

BACKGROUND: Transcranial ultrasound (TCS) can be used to reveal structural changes in the substantia nigra (SN) and is a potential tool for the early diagnosis of Parkinson’s disease (PD). This study aimed to explore the relationship between substantia nigra hyperechogenicity (SNH) and the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Sha, Wang, Yaxi, Jiang, Yinyin, Gu, Ruxin, Zhong, Min, Jiang, Xu, Shen, Bo, Zhu, Jun, Yan, Jun, Pan, Yang, Zhang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356622/ https://www.ncbi.nlm.nih.gov/pubmed/35942277 http://dx.doi.org/10.2147/NDT.S374370

Ejemplares similares

Genetic and constitutional factors are major contributors to substantia nigra hyperechogenicity
por: Vázquez-Costa, Juan F., et al.
Publicado: (2017)

Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s Disease
por: Yilmaz, Rezzak, et al.
Publicado: (2016)

Hyperechogenicity of the Substantia Nigra in Parkinson's Disease: Insights from Two Brothers with Markedly Different Disease Durations
por: Hall, Julie M., et al.
Publicado: (2017)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
por: Zhang, Siyan, et al.
Publicado: (2020)

Substantia nigra hyperechogenicity in Parkinson disease patients with leucine-rich repeat kinase 2 variants in the Chinese Han population
por: Li, Kai, et al.
Publicado: (2020)

Clinical features of minor hallucinations in different phenotypes of Parkinson’s disease: A cross-sectional study
por: Wang, Yaxi, et al.
Publicado: (2023)

Elevation of Plasma Homocysteine and Minor Hallucinations in Parkinson's Disease: A Cross-Sectional Study
por: Zhong, Min, et al.
Publicado: (2022)

Characteristics of sleep structure in Parkinson's disease patients with hallucinations based on polysomnography
por: Gu, Ruxin, et al.
Publicado: (2022)

Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson’s Disease and Atypical Parkinsonian Syndromes
por: Fujita, Hiroaki, et al.
Publicado: (2016)

Gait Analysis with Wearables Is a Potential Progression Marker in Parkinson’s Disease
por: Zhu, Sha, et al.
Publicado: (2022)

Correction: Zhu et al. Gait Analysis with Wearables Is a Potential Progression Marker in Parkinson’s Disease. Brain Sci. 2022, 12, 1213
por: Zhu, Sha, et al.
Publicado: (2023)

Sleep structure and related clinical characteristics in drug-naïve Parkinson's disease with subjectively different sleep quality
por: Jiang, Yinyin, et al.
Publicado: (2023)

Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease
por: Liu, Lei, et al.
Publicado: (2023)

Aberrant gray matter volume and functional connectivity in Parkinson’s disease with minor hallucination
por: Zhong, Min, et al.
Publicado: (2022)

Proteome analysis of human substantia nigra in Parkinson's disease
por: Werner, Cornelius J, et al.
Publicado: (2008)

Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains
por: Gegg, Matthew E, et al.
Publicado: (2012)

Proliferation of Inhibitory Input to the Substantia Nigra in Experimental Parkinsonism
por: Faynveitz, Anna, et al.
Publicado: (2019)

Soemmerring and the Substantia Nigra
por: Faull, R. L. M, et al.
Publicado: (1968)

Alterations of Regional Homogeneity in Parkinson’s Disease with Rapid Eye Movement Sleep Behavior Disorder
por: Jiang, Xu, et al.
Publicado: (2022)

Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study
por: Yu, Shu-yang, et al.
Publicado: (2018)

Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson's Disease in Xinjiang
por: Wei, Rurui, et al.
Publicado: (2023)

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
por: Loeffler, David A, et al.
Publicado: (2006)

Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
por: Dölle, Christian, et al.
Publicado: (2016)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
por: Seyfried, T. N., et al.
Publicado: (2018)

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
por: Trist, Benjamin G., et al.
Publicado: (2019)

Complementary Transcriptomic and Proteomic Analysis in the Substantia Nigra of Parkinson's Disease
por: Dong, Bao-hua, et al.
Publicado: (2021)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
por: Feraco, Paola, et al.
Publicado: (2021)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
por: Hussain, Sayyed Shahid, et al.
Publicado: (2023)

The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
por: Zhou, Hai-Yan, et al.
Publicado: (2018)

Eyes as Gateways for Environmental Light to the Substantia Nigra: Relevance in Parkinson's Disease
por: Romeo, Stefania, et al.
Publicado: (2014)

Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson’s substantia nigra
por: Ayton, Scott, et al.
Publicado: (2016)

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease
por: Reeve, Amy K., et al.
Publicado: (2018)

Corrigendum to: Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease
Publicado: (2020)

Substantia Nigra Integrity Correlates with Sequential Working Memory in Parkinson's Disease
por: Liu, Wenyue, et al.
Publicado: (2021)

Substantia Nigra Radiomics Feature Extraction of Parkinson’s Disease Based on Magnitude Images of Susceptibility-Weighted Imaging
por: Ren, Qingguo, et al.
Publicado: (2021)

Metabolic Disturbances in the Striatum and Substantia Nigra in the Onset and Progression of MPTP-Induced Parkinsonism Model
por: Lu, Yi, et al.
Publicado: (2018)

Electroacupuncture-regulated neurotrophic factor mRNA expression in the substantia nigra of Parkinson's disease rats
por: Wang, Shuju, et al.
Publicado: (2013)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2020)

Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson’s disease
por: Zarbakhsh, Sam, et al.
Publicado: (2019)

Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson’s disease: A Systematic Review and Meta-analysis
por: Li, Dun-Hui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ubi77m2mdco07n79pg3ooa93l2